Ashland upgraded by Seaport Research Partners with a new price target
$ASH
Specialty Chemicals
Consumer Discretionary
Seaport Research Partners upgraded Ashland from Neutral to Buy and set a new price target of $75.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/6/2026 | $75.00 | Neutral → Buy | Seaport Research Partners |
| 12/15/2025 | $71.00 | Market Perform → Outperform | BMO Capital Markets |
| 9/8/2025 | $60.00 | Equal-Weight | Morgan Stanley |
| 5/1/2025 | Overweight → Equal Weight | Wells Fargo | |
| 3/26/2025 | $68.00 → $71.00 | Neutral → Overweight | Analyst |
| 3/5/2025 | Buy → Neutral | Seaport Research Partners | |
| 8/8/2024 | $90.00 → $89.00 | Underweight → Neutral | JP Morgan |
| 4/11/2024 | $100.00 → $112.00 | Equal Weight → Overweight | Wells Fargo |
WILMINGTON, Del., June 10, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today issued the following statement in response to the investor presentation released by Ancora Alternatives LLC: Ashland's Board of Directors and management team are committed to driving sustainable value creation for all shareholders. The Board recognizes and respects diverse perspectives and welcomes constructive input from shareholders. While Ancora did not engage with Ashland prior to its presentation, Ashland intends to engage with Ancora in a manner consistent with that commitment as part of its ongoing dialogue with investors. Ashland remains focused on its growth strategies to execute, globalize, inno
Believes Ashland's High-Margin, Strategically Scarce Assets Are Being Undervalued by the Public Markets in the Face of Near-Term Growth and Execution Issues Urges Ashland's Board to Conduct a Full Review of Strategic Alternatives, Including Evaluating Sale Options Following Apparent Interest from Standard Industries as Well as Other Strategic and Private Equity Buyers Releases Presentation Outlining How a Sale Could Yield ~$76 Per Share or More, Representing a More Than 33% Premium and Likely the Best Risk-Adjusted Path Forward Ancora Holdings Group, LLC (collectively with its affiliates, "Ancora") today released a presentation (available here) detailing what it believes is a near-ter
WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,
11-K - ASHLAND INC. (0001674862) (Filer)
11-K - ASHLAND INC. (0001674862) (Filer)
11-K - ASHLAND INC. (0001674862) (Filer)
WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan
Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu
4 - ASHLAND INC. (0001674862) (Issuer)
3 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
Seaport Research Partners upgraded Ashland from Neutral to Buy and set a new price target of $75.00
BMO Capital Markets upgraded Ashland from Market Perform to Outperform and set a new price target of $71.00
Morgan Stanley initiated coverage of Ashland with a rating of Equal-Weight and set a new price target of $60.00
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND INC. (0001674862) (Subject)
Believes Ashland's High-Margin, Strategically Scarce Assets Are Being Undervalued by the Public Markets in the Face of Near-Term Growth and Execution Issues Urges Ashland's Board to Conduct a Full Review of Strategic Alternatives, Including Evaluating Sale Options Following Apparent Interest from Standard Industries as Well as Other Strategic and Private Equity Buyers Releases Presentation Outlining How a Sale Could Yield ~$76 Per Share or More, Representing a More Than 33% Premium and Likely the Best Risk-Adjusted Path Forward Ancora Holdings Group, LLC (collectively with its affiliates, "Ancora") today released a presentation (available here) detailing what it believes is a near-ter
WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock which represents a 1.2 percent increase from the previous quarter. The dividend will be payable on June 15, 2026, to stockholders of record at the close of business on June 1, 2026. As of April 30, 2026, there were 45,788,007 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of co
Sales of $482 million, up one percent from the prior-year quarterIncome from continuing operations of $15 million, or $0.32 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $42 million, or $0.91 per diluted shareNet income of $16 million, or $0.34 per diluted shareAdjusted EBITDA of $98 million, down nine percent from the prior-year quarter, primarily reflecting temporary operational impacts from the Calvert City startup delay, Hopewell productivity challenges, and weather-related disruptions in the second quarterCash flows provided by operating activities of $50 million; Ongoing Free Cash Flow2 of $29 millionUpdating full‑year fiscal